Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recomb…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Aeglea BioTherapeutics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Aeglea BioTherapeutics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Aeglea BioTherapeutics, Inc..